Roche Nigeria has restated its commitment to improve outcomes for everyone suffering from cancer in Nigeria.
To achieve this, the pharmaceutical company has invested resources to ensure that patients with breast cancer, the most frequently occurring and most common cause of cancer death in Nigeria, are properly diagnosed and treated.
Country Manager, Roche Nigeria, Ladi Hammed, in a statement issued to commemorate the just ended World Cancer Day, pointed out that the international observance of Cancer Day is a clarion call to remember everyone that has lost a friend or relative to cancer as well as those presently battling the disease.
In addition, he stated that the Cancer Day presented an opportunity to renew the collective commitment to fight the scourge as a community and as a nation.
He said: “As a vested stakeholder, Roche Nigeria has consistently invested in research and development, capability and capacity building to ensure that patients with breast cancer, the most frequently occurring and most common cause of cancer death in Nigeria, are properly diagnosed and treated. However, we realize that this is not enough as the numbers of sufferers have not reduced and their pain has not gone away”.
“In Nigeria, we have over 38,000 female deaths and over 30,000 male deaths to different forms of cancer led by breast and cervical for women, prostate and liver for men. Risk factors including smoking, significant alcohol consumption, physical inactivity and obesity are also on the rise.
“While government prioritization and policy direction have clearly improved in the past year and we applaud this development at all levels, there is still more to be done and it will take the collective effort of all stakeholders”, he added.
Join Daily Trust WhatsApp Community For Quick Access To News and Happenings Around You.
